OVERSEA CHINESE BANKING Corp Ltd acquired a new position in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 23,992 shares of the real estate investment trust's stock, valued at approximately $2,017,000. OVERSEA CHINESE BANKING Corp Ltd owned approximately 0.06% of National Health Investors at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Strategic Financial Concepts LLC purchased a new stake in shares of National Health Investors during the second quarter valued at approximately $28,000. Covestor Ltd increased its holdings in shares of National Health Investors by 2,700.0% in the 3rd quarter. Covestor Ltd now owns 420 shares of the real estate investment trust's stock worth $35,000 after purchasing an additional 405 shares in the last quarter. International Assets Investment Management LLC purchased a new position in National Health Investors in the 2nd quarter worth about $36,000. Blue Trust Inc. lifted its position in National Health Investors by 2,651.9% during the second quarter. Blue Trust Inc. now owns 743 shares of the real estate investment trust's stock valued at $47,000 after purchasing an additional 716 shares during the period. Finally, Assetmark Inc. boosted its stake in shares of National Health Investors by 27.8% in the 3rd quarter. Assetmark Inc. now owns 648 shares of the real estate investment trust's stock worth $54,000 after buying an additional 141 shares during the last quarter. Hedge funds and other institutional investors own 62.51% of the company's stock.
National Health Investors Price Performance
Shares of NHI traded down $2.05 during mid-day trading on Wednesday, reaching $78.21. The stock had a trading volume of 285,884 shares, compared to its average volume of 196,698. The firm has a market cap of $3.55 billion, a price-to-earnings ratio of 26.87, a PEG ratio of 5.36 and a beta of 1.05. National Health Investors, Inc. has a 12 month low of $51.59 and a 12 month high of $86.13. The business has a fifty day moving average of $80.35 and a 200 day moving average of $73.74. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29.
National Health Investors (NYSE:NHI - Get Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.07 by ($0.42). National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The business had revenue of $63.32 million during the quarter, compared to analysts' expectations of $67.93 million. During the same quarter in the previous year, the company posted $1.08 EPS. The company's quarterly revenue was up 1.7% on a year-over-year basis. Equities analysts predict that National Health Investors, Inc. will post 4.42 EPS for the current year.
National Health Investors Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be issued a $0.90 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a yield of 4.60%. National Health Investors's dividend payout ratio is presently 123.71%.
Analyst Ratings Changes
Several research analysts have issued reports on NHI shares. Bank of America began coverage on National Health Investors in a research report on Tuesday, September 24th. They issued a "buy" rating and a $92.00 target price on the stock. Truist Financial raised their price objective on shares of National Health Investors from $65.00 to $78.00 and gave the stock a "hold" rating in a report on Friday, August 30th. Wells Fargo & Company cut shares of National Health Investors from an "overweight" rating to an "equal weight" rating and upped their target price for the company from $81.00 to $86.00 in a report on Tuesday, October 1st. Finally, StockNews.com cut shares of National Health Investors from a "buy" rating to a "hold" rating in a research note on Tuesday, October 15th. Four analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $73.29.
Check Out Our Latest Stock Analysis on NHI
National Health Investors Company Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
